Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiparametric MRI Assessment of Atrial Heart Disease as a Predictor of POAF
NCT04657835Not yet recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoint: Predictive value of atrial heart disease characterized by multiparametric MRI for the recurrence of atrial fibrillation at 12 months. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT04657835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657835.